Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Emerging medical therapies for severe alcoholic hepatitis

David Tornai, Gyongyi Szabo

Clin Mol Hepatol. 2020;26(4):686-696. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0145

View: 5921 Download: 218 Web of Science: 15 Crossref: 15

Review

NADPH oxidase mediated oxidative stress in hepatic fibrogenesis

Yong-Han Paik, David A. Brenner

Clin Mol Hepatol. 2011;17(4):251-257. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.251

View: 9453 Download: 77 Crossref: 40

2

Nonalcoholic steatohepatitis: Pathogenesis and treatment

Sang Hoon Park

Clin Mol Hepatol. 2008;14(1):12-27. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.12

View: 6852 Download: 105 Crossref: 5

3

Lipid Peroxidation in Chronic Liver Diseases Type B

Kyung Chul Kim , Kwan Sik Lee , Kwang Hyub Han , Won Choi , Chae Yoon Chon , Sang In Lee , Young Myung Moon , Jin Kyung Kang , In Suh Park , Hye Young Kim

Clin Mol Hepatol. 1997;3(1):40-49.

View: 2344 Download: 18

1 |

Viewed By 5387	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5339	MAFLD: How is it different from NAFLD?
Viewed By 5227	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3909	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3877	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search